Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut - Reuters

Reuters | Feb. 6, 2026, 12:48 p.m. | Original
Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut Reuters
Exclusive: Williams weighs buying gas-producing assets to enhance AI energy supply to hyperscalers, sources say - Reuters Jennifer Garner's Once Upon a Farm valued at nearly $845 million in NYSE debut - Reuters